Sixty-nine percent of autistic children randomly assigned to receive the new anti-psychotic drug risperidone improved at the end of an eight-week clinical study, compared with only 12 percent in the placebo group, the largest positive effect by a medication ever observed in children with autism.
http://www.nimh.nih.gov/events/prautismmeds.cfm?LS=5